登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：003021 证券简称：兆威机电 公告编号：2026-005 2026年1月30日，公司在香港联交所网站刊登了本次发行并上市聆讯后资料集。具体内容详见公司于 2026年1月31日在巨潮资讯网（http://www.cninfo.com.cn）披露的《关于刊发H股发行聆讯后资料集的公 告》（公告编号：2026-004）。 深圳市兆威机电股份有限公司 关于刊发H股招股说明书、H股发行价格上限 及H股香港公开发售等事宜的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 深圳市兆威机电股份有限公司（以下简称"公司"）正在进行申请发行境外上市外资股（H股）并在香港 联合交易所有限公司（以下简称"香港联交所"）主板挂牌上市（以下简称"本次发行并上市"）的相关工 作。 2025年6月18日，公司向香港联交所递交了本次发行并上市的申请，并于同日在香港联交所网站刊登了 本次发行并上市的申请资料；根据本次发行并上市计划并根据香港联交所的相关规定，公司于2025年12 月19日向香港联交所更新递交了本次发行并上市的申请 ...

Group 1 - The company, Shenzhen Xinlitai Pharmaceutical Co., Ltd., submitted an application for issuing H-shares and listing on the Hong Kong Stock Exchange on February 12, 2026 [1][2] - The application materials were published on the Hong Kong Stock Exchange website and are subject to updates and revisions as required by the Hong Kong Securities and Futures Commission and the Hong Kong Stock Exchange [1][2] - If the issuance and listing are implemented, the target investors will be limited to qualified foreign investors and domestic qualified investors authorized to conduct overseas securities investments according to Chinese laws and regulations [1][2] Group 2 - The announcement serves to inform domestic investors about the issuance and listing, and does not constitute an offer or invitation to purchase the H-shares [2] - The issuance and listing are subject to approvals from relevant government agencies and regulatory bodies, including the China Securities Regulatory Commission, the Hong Kong Securities and Futures Commission, and the Hong Kong Stock Exchange, indicating uncertainty in the process [2] - The company will fulfill its information disclosure obligations in accordance with the progress of the matter [2]

鹏辉能源（300438）(300438.SZ)发布公告，公司已于2026年1月30日向香港联交所递交了发行境外上市 外资股(H股)并在香港联交所主板挂牌上市的申请，并于同日在香港联交所网站刊登了本次发行并上市 的申请资料。本次发行并上市事项的相关申请资料为公司按照香港证监会和香港联交所的要求编制和刊 发，为草拟版本，且所载资料可能会适时作出更新及修订。 ...

新泉股份（603179）(603179.SH)发布公告，公司于2026年1月27日向香港联合交易所有限公司(简称"香 港联交所")递交了发行H股股票并在香港联交所主板上市的申请，并于同日在香港联交所网站刊登了本 次发行上市的申请资料。该申请资料为公司按照香港证券及期货事务监察委员会(简称"香港证监会")及 香港联交所的要求编制和刊发，为草拟版本，其所载资料可能会适时作出更新及修订。 ...

德业股份公告，公司已于2026年1月27日向香港联合交易所有限公司递交了发行H股股票并在香港联交 所主板挂牌上市的申请，并于同日在香港联交所网站刊登了本次发行上市的申请资料。 ...

Core Viewpoint - The company, Jucheng Semiconductor Co., Ltd., has submitted an application for the issuance and listing of H-shares on the Hong Kong Stock Exchange, aiming to expand its capital base and attract foreign investment [1][2]. Group 1 - The company submitted its application to the Hong Kong Stock Exchange on January 26, 2026, for the issuance of H-shares and listing on the main board [1]. - The application materials have been published on the Hong Kong Stock Exchange's website and are subject to updates and revisions as required by regulatory authorities [1][2]. - The issuance is limited to qualified foreign investors and certain domestic qualified investors, and the company will not publish the application materials on domestic exchanges [2]. Group 2 - The approval from the China Securities Regulatory Commission, the Hong Kong Securities and Futures Commission, and the Hong Kong Stock Exchange is required for the H-share issuance, indicating potential uncertainties in the process [3]. - The company will fulfill its information disclosure obligations in accordance with relevant laws and regulations as the process progresses [3].

拓斯达（300607）(300607.SZ)公告，公司于2026年1月16日向中国香港联交所递交了发行H股股票并在 联交所主板挂牌上市的申请，并于同日在联交所网站刊登了本次发行上市的申请材料。 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002203 证券简称：海亮股份 公告编号：2026-001 浙江海亮股份有限公司 第九届董事会第六次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 浙江海亮股份有限公司（以下简称"公司"）第九届董事会第六次会议通知于2026年1月6日以电子邮件、 电话传真或送达书面通知的方式发出，会议于2026年1月7日下午在浙江省杭州市滨江区协同路368号海 亮科研大厦公司会议室召开，本次会议以现场表决和通讯表决相结合方式召开，会议应到董事九名，实 到董事九名，公司高级管理人员列席本次会议。本次会议由董事长冯橹铭先生主持。 本次会议出席人数、召开程序、议事内容均符合《中华人民共和国公司法》和《浙江海亮股份有限公司 章程》的规定，决议合法有效。 经全体董事认真审阅并在议案表决书上表决签字，会议审议通过了如下议案： 一、审议通过了《关于修订公司于H股发行上市后适用的〈公司章程（草案）〉及相关议事规则（草 案）的议案》 董事会同意根据《中华人民共和国公司法》《境内企业境外发行证券和上市管理试行办法》《香港 ...

Core Viewpoint - The company is in the process of applying for the public issuance of H-shares and listing on the Hong Kong Stock Exchange, with the application submitted on June 27, 2025, and updated on December 29, 2025 [1][2]. Group 1: Issuance and Listing Progress - The company has submitted its application for the issuance of H-shares to the Hong Kong Stock Exchange and published the application materials on the same day [1]. - An update to the issuance application, including company information and financial data, was submitted to the Hong Kong Stock Exchange on December 29, 2025 [1]. - The application materials are prepared in accordance with the requirements of the Hong Kong Stock Exchange and the Hong Kong Securities and Futures Commission, and may be updated or revised [1]. Group 2: Investor Information - The issuance and listing are limited to qualified overseas investors and domestic qualified investors under Chinese laws, and the application materials will not be published on domestic exchanges [2]. - A link to the application materials on the Hong Kong Stock Exchange website is provided for domestic investors to access relevant information [2]. Group 3: Regulatory Approval - The issuance and listing are subject to approvals from the Hong Kong Securities and Futures Commission, the Hong Kong Stock Exchange, and the China Securities Regulatory Commission, indicating uncertainty in the process [3]. - The company will fulfill its information disclosure obligations in accordance with the progress of these approvals [3].

Core Viewpoint - The company, 澜起科技, has announced the approval of several proposals during the 13th meeting of the third board of directors, including plans for an initial public offering (IPO) of H-shares and listing on the Hong Kong Stock Exchange [1] Group 1: IPO and Listing - The board has agreed to the arrangements for the initial public offering of H-shares and authorized the handling of specific matters related to the issuance and listing [1] - The company will revise its articles of association to take effect after the issuance and listing of H-shares, in line with actual circumstances [1] Group 2: Stock Incentives - The company will grant 11.4 million restricted shares to two incentive targets at a price of 45.91 yuan per share, with the grant date set for a day in 2025 [1] - Directors Yang Chonghe and Stephen Kuong - Io Tai abstained from voting on this proposal due to the nature of the incentive [1]